President Donald Trump has begun his second administration with a series of controversial moves and decisions.
Roche descendant André Hoffmann talks pharma, feuds and ESG as he takes a stand against ‘arrogance’ of Trump and Musk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback